[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
Nov 14, 2011

Acid Suppressive Therapy in Noncritically Ill Patients—Reply

Author Affiliations

Author Affiliations: Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Arch Intern Med. 2011;171(20):1862-1864. doi:10.1001/archinternmed.2011.514

In reply

We thank Barletta and El-Ibiary for their insightful comments. We wholeheartedly agree regarding the importance of attempting to identify subgroups of hospitalized, noncritically ill patients with heightened risk for nosocomial GI bleeding to determine if risk is high enough to warrant routine prophylaxis with acid-suppressive medication. Such analyses in critically ill patients were instrumental in identifying high- and low-risk subgroups of patients with numbers needed to treat of 30 and 900, respectively.1 We are currently completing such analyses in our large cohort of hospitalized, noncritically ill patients and hope to shed light on this issue in the future.

First Page Preview View Large
First page PDF preview
First page PDF preview
×